<DOC>
	<DOCNO>NCT00507234</DOCNO>
	<brief_summary>This multicenter , Phase IIIb , randomize , double-blind , active-controlled , parallel-group , comparative study . The objective study : 1 . To compare efficacy tiotropium 18 mcg daily plus Formoterol Fumarate Inhalation Solution ( FFIS ) 20 mcg twice daily tiotropium 18 mcg daily . 2 . To obtain safety data use tiotropium 18 mcg daily plus FFIS 20 mcg twice daily compare tiotropium 18 mcg daily .</brief_summary>
	<brief_title>Study Subjects Greater Than 40 Years Age With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Medical diagnosis COPD Current prior history cigarette smoke Medical diagnosis asthma Significant condition disease COPD</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>COPD</keyword>
</DOC>